Inventor
QU HONGCHANG
US20 patents
⚠️ This page may combine multiple inventors who share the name “QU HONGCHANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
15 patentsUS11542313B2Jan 3, 2023
Incretin analogs and uses thereof
LILLY CO ELI7 citations85
US11254721B2Feb 22, 2022
GIPR-agonist compounds
LILLY CO ELI5 citations80
US11084861B2Aug 10, 2021
GIP/GLP1 co-agonist compounds
LILLY CO ELI6 citations77
US11834486B2Dec 5, 2023
Incretin analogs and uses thereof
LILLY CO ELI3 citations72
US11897926B2Feb 13, 2024
GIPR-agonist compounds
LILLY CO ELI3 citations71
US9938335B2Apr 10, 2018
Glucagon and GLP-1 co-agonist compounds
LILLY CO ELI6 citations69
US12558430B2Feb 24, 2026
Dual amylin and calcitonin receptor agonists and uses thereof
LILLY CO ELI0 citations62
US12371465B2Jul 29, 2025
Incretin analogs and uses thereof
LILLY CO ELI0 citations62
US12365716B2Jul 22, 2025
Incretin analogs and uses thereof
LILLY CO ELI0 citations62
US11541123B2Jan 3, 2023
Dual amylin and calcitonin receptor agonists and uses thereof
LILLY CO ELI0 citations62
US12551566B2Feb 17, 2026
Dual amylin and calcitonin receptor agonists and uses thereof
LILLY CO ELI0 citations59
US12551532B2Feb 17, 2026
Long-acting amylin receptor agonists and uses thereof
LILLY CO ELI0 citations59
US12115210B2Oct 15, 2024
Long acting amylin receptor agonists and uses thereof
LILLY CO ELI0 citations59
US12252524B2Mar 18, 2025
GIP/GLP1 co-agonist compounds
LILLY CO ELI0 citations53
US12410227B2Sep 9, 2025
Incretin analogs and uses thereof
LILLY CO ELI0 citations48
UNIV PENNSYLVANIA
3 patentsUS9371365B2Jun 21, 2016
Modified compstatin with peptide backbone and C-terminal modifications
UNIV PENNSYLVANIA22 citations92
US10174079B2Jan 8, 2019
Compstatin analogs with improved pharmacokinetic properties
UNIV PENNSYLVANIA4 citations82
US10745442B2Aug 18, 2020
Compstatin analogs with improved pharmacokinetic properties
UNIV PENNSYLVANIA2 citations71